WellTheory Raises $14M Series A Led by General Catalyst

Deal Summary

WellTheory, a San Francisco-based whole-person care platform for autoimmune disease, raised $14M in a Series A round led by General Catalyst with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer and Up2 Opportunity Fund. The round brings the company’s total funding to $26.2M.